丙型肝炎失代偿期肝硬化患者的抗病毒治疗和长期临床结局分析(1)
[摘要] 目的 分析丙型肝炎失代偿期肝硬化患者抗病毒治疗与长期临床结局。 方法 随机选取该院2014年9月—2015年9月收治的丙型肝炎失代偿期肝硬化100例患者临床资料进行回顾性分析，由小剂量干扰素逐渐加量行PEG-IFNα-2a或PEG-IFNα-2b与利巴韦林联合治疗，对患者病毒学的应答情况进行评估，包括复发、SVR与无应答。结果 SVR组肝功能失代偿率14.29%(5/35)均比复发组31.25%(10/32)与无应答组78.79%(26/33)低，且复发组、SVR组血小板计数均升高(P<0.05)。结论 丙型肝炎失代偿期肝硬化患者采用小剂量干扰素逐渐加量与利巴韦林联合治疗可取得良好临床结局。
[关键词] 丙型肝炎；失代偿期肝硬化；抗病毒
[中图分类号] R4 [文献标识码] A [文章编号] 1674-0742(2016)05(c)-0079-02
[Abstract] Objective To analyze the antiviral treatment and long-term clinical outcomes of patients with hepatitis c decompensated cirrhosis. Methods The clinical data of 100 cases of patients with hepatitis c decompensated cirrhosis admitted and treated in our hospital from September 2014 to September 2015 were retrospectively analyzed ......
您现在查看是摘要页，全文长 3287 字符。
[关键词] 丙型肝炎；失代偿期肝硬化；抗病毒
[中图分类号] R4 [文献标识码] A [文章编号] 1674-0742(2016)05(c)-0079-02
[Abstract] Objective To analyze the antiviral treatment and long-term clinical outcomes of patients with hepatitis c decompensated cirrhosis. Methods The clinical data of 100 cases of patients with hepatitis c decompensated cirrhosis admitted and treated in our hospital from September 2014 to September 2015 were retrospectively analyzed ......
您现在查看是摘要页，全文长 3287 字符。